MedPath

Effects of preprandial administration of high-dose metformin on postprandial hypertriglyceridemia.

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000022699
Lead Sponsor
Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) Receiving drugs that affect gastrointestinal motility (Glucagon-like peptide-1 analogue, or anticholinergic drug, etc.) 2) Has history of pancreatitis 3) With severe autonomic dysfunction (orthostatic hypotension, or neurogenic bladder, etc.) 4) Has history of intestinal obstruction after upper gastrointestinal surgery or hepato-biliary-pancreatic surgery 5) Receiving treatment for cancers 6) During pregnancy or lactation 7) With contraindications to metformin (history of lactic acidosis, or moderate and severe renal impairment, etc.) 8) Considered inadequate by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath